Gonzalo Barón Esquivias-rekin lankidetzan egindako argitalpenak (14)

2024

  1. Practical use of new therapies for the management of dyslipidaemias. Consensus SEC/SEA/SEEN/SEMFYC/SEMERGEN/SEMG/SEN/SEACV/S.E.N.

    REC: CardioClinics, Vol. 59, Núm. 4, pp. 310-321

2023

  1. Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban

    Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049

2022

  1. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

    Cardiology Journal, Vol. 29, Núm. 6, pp. 936-947

  2. Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study

    Cardiology Journal, Vol. 29, Núm. 4, pp. 601-609

  3. Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries

    Journal of comparative effectiveness research, Vol. 11, Núm. 16, pp. 1173-1184

  4. Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

    European Journal of Clinical Investigation

2020

  1. Patients with a high cardiovascular risk and atrial fibrillation: the role of rivaroxaban

    Revista Espanola de Cardiologia Suplementos, Vol. 20, pp. 30-38

  2. Quality of life, medication adherence and satisfaction with anticoagulant treatment (dabigatran vs vitamin K antagonists) according to thromboembolic risk. Data from the CAPANA study

    International Journal of Clinical Practice

2019

  1. Quality of life, adherence and satisfaction of patients with auricular fibrillation treated with dabigatran or vitamin K antagonists

    Revista Clinica Espanola, Vol. 219, Núm. 6, pp. 285-292

2015

  1. Update for 2014 on clinical cardiology, geriatric cardiology, and heart failure and transplantation

    Revista Espanola de Cardiologia, Vol. 68, Núm. 4, pp. 317-323

2014

  1. Algoritmos de comorbilidad en fibrilación auricular

    Jarpyo

  2. Fibrilación auricular no valvular y anticoagulación: evidencia y experiencia en situaciones específicas con Dabigatrán

    Medical & Marketing Communications

2013

  1. Actualización en insuficiencia cardiaca, trasplante cardiaco, cardiopatías congénitas y cardiología clínica

    Revista Espanola de Cardiologia, Vol. 66, Núm. 4, pp. 290-297

2011

  1. Comments on the ESC/EAS guidelines for the management of dyslipidaemias 2011. A report of the task force of the clinical practice guidelines committee of the Spanish society of cardiology

    Revista Espanola de Cardiologia, Vol. 64, Núm. 12, pp. 1090-1095